Stock screenerAll disclosures →
EDGAR →
XOMA
Conviction 92HealthcareScan · Fri, Jun 26, 2026XOMA$42.14-0.14%
ResistanceSupportVol 14Vol MA14 135.35K
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price42.14
Change-0.14%
Gap-0.13%
Rel volume3.09×
Avg volume120.76K
Avg $ vol5.07M
SMA 2041.91
SMA 5041.37
SMA 20033.40
Price vs 50+1.86%
Price vs 200+26.17%
MA stackbullish
50/200 cross—
Supertrendup · 40.92
RSI (14)62
MACD hist-0.08
MACD cross—
Stoch %K / %D82 / 84
ADX (14)32
+DI / −DI22 / 22
RSI divergence—
MACD divergenceBullish
ATR %+1.16%
ADR %0.93%
52w high42.40
52w low22.89
From 52w high-0.61%
Above 52w low+84.10%
New 52w highNo
SqueezeOn · 24d
Bollinger width1.86%
%B0.79
Donchian pos81.66%
Donchian high42.45
Donchian low40.76
AVWAP (52w high)41.62
vs AVWAP high+1.26%
AVWAP (52w low)37.24
vs AVWAP low+13.17%
OBV trendFlat
Chaikin MF (20)0.00
Today vs 20d3.09×
Avg vol (14d)135.35K
Avg vol (20d)120.76K
Avg $ vol (20d)5.07M
Market cap—
RS 3m (vs SPY)+27.94%
RS 6m (vs SPY)+57.75%
RS line new highNo
Trend template6/8
Technical rank81.0
1 week+0.60%
1 month+0.96%
3 months+38.03%
6 months+65.32%
1 year+53.52%
YTD+50.55%
P/E16.69
P/B5.70
P/S51.13
P/FCF185.63
EPS1.46
Div yield1.03%
ROE34.14%
ROA11.66%
Debt/Eq1.11
Current3.59
EV/EBITDA47.88
Gross margin—
Net margin306.40%
Rev growth55.64%
EPS growth329.45%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value546.47M
Revenue225K
Net income4.46M
Gross profit—
Free cash flow2.85M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out17.68M
Employees14
ListedFri, Jun 6, 1986
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA+
Conviction92 / 100
Pattern quality—
Tech rank81.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance42.31
Support40.98
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in XOMA
No recent disclosed trades by Congress in XOMA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in XOMA · 6 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
LIMBER JOSEPH M Director · 8.625% Series A Cumulative Perpetual Preferred Stock · 2026-05-21 | Other | — | — | 2026-05-21 | 2026-05-26 |
Hernday Natasha Director · Common Stock · 2026-05-21 | Grant | 3.59K | $0 | 2026-05-21 | 2026-05-26 |
Kosacz Barbara Director · Common Stock · 2026-05-21 | Grant | 3.59K | $0 | 2026-05-21 | 2026-05-26 |
LIMBER JOSEPH M Director · Common Stock · 2026-05-21 | Grant | 3.59K | $0 | 2026-05-21 | 2026-05-26 |
WYSZOMIERSKI JACK L Director · Common Stock · 2026-05-21 | Grant | 3.59K | $0 | 2026-05-21 | 2026-05-26 |
LIMBER JOSEPH M Director · Depositary Shares - 8.375% B Cumulative Stock · 2026-05-21 | Other | — | — | 2026-05-21 | 2026-05-26 |
PERRY MATTHEW D Director · Common Stock · 2026-05-21 | Grant | 3.59K | $0 | 2026-05-21 | 2026-05-26 |
Hernday Natasha Director · 8.625% Series A Cumulative Perpetual Preferred Stock · 2026-05-21 | Other | — | — | 2026-05-21 | 2026-05-26 |
Franklin Heather L Director · Common Stock · 2026-05-21 | Grant | 3.59K | $0 | 2026-05-21 | 2026-05-26 |
BVF PARTNERS L P/IL 10% owner · Series X Convertible Preferred Stock · 2026-05-14 | Convert | 2.31K | $0 | 2026-05-14 | 2026-05-18 |
SEC filings
EDGAR filings in XOMA · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.